Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pigment Cell & Melanoma Research

• Publication date

  2008-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1755-148X.2008.00484.xPMID 18627528
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2008

  2008cited by this paper
• Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL

  2008cited by this paper
• Methylation of CpG island promoters in uveal melanoma

  2008cited by this paper
• Silencing of tissue factor pathway inhibitor‐2 gene in malignant melanomas

  2007cited by this paper
• MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)*

  2007cited by this paper
• Epigenetic events in malignant melanoma.

  2007cited by this paper
• Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells.

  2007cited by this paper
• Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.

  2007cited by this paper
• Paradoxical roles for lysyl oxidases in cancer—A prospect

  2007cited by this paper
• Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors.

  2007cited by this paper
• Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.

  2007cited by this paper
• The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.

  2007cited by this paper
• Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.

  2006cited by this paper
• Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non‐small cell lung cancer

  2006cited by this paper
• Lysyl oxidase is essential for hypoxia-induced metastasis

  2006cited by this paper
• Epigenetic silencing of the PTEN gene in melanoma.

  2006cited by this paper
• Epigenetic silencing of novel tumor suppressors in malignant melanoma.

  2006influential reference
• Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer.

  2006cited by this paper
• Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.

  2006cited by this paper
• Malignant melanoma: genetics and therapeutics in the genomic era.

  2006cited by this paper
• Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-β

  2005cited by this paper
• Silencing of the thrombomodulin gene in human malignant melanoma

  2005cited by this paper
• Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

  2005cited by this paper
• Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.

  2005cited by this paper
• Isolation and culture of melanoma cell lines.

  2004cited by this paper
• Promoter methylation of the PTEN gene is a common molecular change in breast cancer

  2004cited by this paper
• Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma

  2004cited by this paper
• Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

  2004cited by this paper
• Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines.

  2004cited by this paper
• Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients

  2004cited by this paper
• CpG island methylator phenotype in cancer

  2004cited by this paper
• Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer

  2004cited by this paper
• Promoter methylation profiling of 30 genes in human malignant melanoma

  2004cited by this paper
• Genetic and epigenetic alterations of the APC gene in malignant melanoma

  2004cited by this paper
• Lysyl Oxidase Is a Tumor Suppressor Gene Inactivated by Methylation and Loss of Heterozygosity in Human Gastric Cancers

  2004cited by this paper
• ASC/TMS1, a caspase‐1 activating adaptor, is downregulated by aberrant metylation in human melanoma

  2003cited by this paper
• Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.

  2003cited by this paper
• A molecular role for lysyl oxidase in breast cancer invasion.

  2002cited by this paper
• Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation.

  2002cited by this paper
• Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors

  2002cited by this paper
• E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.

  2000cited by this paper
• Aberrant p27Kip1 promoter methylation in malignant melanoma

  2000cited by this paper
• Death and decoy receptors and p53-mediated apoptosis

  2000cited by this paper
• A new American Joint Committee on Cancer staging system for cutaneous melanoma

  2000cited by this paper
• Regulation of the Promoter Activity of Interferon Regulatory Factor-7 Gene

  2000cited by this paper
• Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: advances in the monitoring of patients with metastatic melanoma.

  1999cited by this paper
• Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors.

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• High sensitivity mapping of methylated cytosines.

  1994cited by this paper
• Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity.

  1994cited by this paper
• Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• A new experimental metastasis model in athymic nude mice, the human malignant melanoma lox

  1988cited by this paper
• Deficient production of lysyi oxidase in cultures of malignantly transformed human cells

  1986cited by this paper

• Epigenetic Therapies in Melanoma—Targeting DNA Methylation and Histone Modification

  2025cites this paper
• DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance

  2024cites this paper
• Advances in Understanding Drug Resistance Mechanisms and Innovative Clinical Treatments for Melanoma

  2024cites this paper
• SOCS1 as a Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas

  2023cites this paper
• The Mechanism of DNA Methylation and miRNA in Breast Cancer

  2023cites this paper
• DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective

  2023cites this paper
• Mast cell marker gene signature in head and neck squamous cell carcinoma

  2022cites this paper
• Structure and Function of TET Enzymes.

  2022cites this paper
• Multiomics to investigate the mechanisms contributing to repression of PTPRC and SOCS2 in pediatric T‐ALL: Focus on miR‐363‐3p and promoter methylation

  2022cites this paper
• Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises.

  2022cites this paper
• Phosphorylation-Induced Conformational Dynamics and Inhibition of Janus Kinase 1 by Suppressors of Cytokine Signaling 1.

  2022cites this paper
• The Emerging Role of Suppressors of Cytokine Signaling (SOCS) in the Development and Progression of Leukemia

  2021cites this paper
• Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy

  2021influential citation
• Molecular structure, gene expression and functional role of WFDC1 in angiogenesis and cancer.

  2021cites this paper
• HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.

  2021cites this paper
• Uveal melanoma: progress in molecular biology and therapeutics

  2020cites this paper
• Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer

  2020cites this paper
• Phylogenetic, molecular evolution and structural analyses of the WFDC1/prostate stromal protein 20 (ps20).

  2019cites this paper
• Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer

  2019cites this paper
• All trans-retinoic acid protects against acute ischemic stroke by modulating neutrophil functions through STAT1 signaling

  2019cites this paper
• SOCS1 and its Potential Clinical Role in Tumor

  2019cites this paper
• Dual-functionality of RASSF1A overexpression in A375 cells is mediated by activation of IL-6/STAT3 regulatory loop

  2018cites this paper
• Epigenetics in Melanoma

  2018cites this paper
• Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta‐analysis

  2018cites this paper
• Clinical and Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Melanoma: A Systematic Meta-Analysis

  2018cites this paper
• Genetic and epigenetic insights into uveal melanoma

  2018cites this paper
• From chemo-prevention to epigenetic regulation: The role of isothiocyanates in skin cancer prevention.

  2018cites this paper
• The molecular basis of JAK/STAT inhibition by SOCS1

  2018cites this paper
• DNA methylation/hydroxymethylation in melanoma

  2017influential citation
• The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics

  2017cites this paper
• HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance

  2017cites this paper
• Identification of biomarkers for the management of human prostate cancer

  2017cites this paper
• Casticin inhibits the activity of transcription factor Sp1 and the methylation of RECK in MGC803 gastric cancer cells.

  2017cites this paper
• SOCS1 function in BCR-ABL mediated myeloproliferative disease is dependent on the cytokine environment

  2017cites this paper
• Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia

  2017cites this paper
• Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities

  2017influential citation
• Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma

  2017cites this paper
• Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration.

  2016cites this paper
• scan_tcga tools for integrated epigenomic and transcriptomic analysis of tumor subgroups.

  2016cites this paper
• IL‐8 induces miR‐424‐5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma

  2016cites this paper
• DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.

  2016cites this paper
• SOCS2: physiological and pathological functions.

  2016cites this paper
• Pre-neoplastic epigenetic disruption of transcriptional enhancers in chronic inflammation

  2016cites this paper
• Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma

  2016cites this paper
• Targeting JAK kinase in solid tumors: emerging opportunities and challenges

  2016cites this paper
• Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma.

  2016cites this paper
• Structure and Function of TET Enzymes.

  2016cites this paper
• Bidirectional cross talk between patient‐derived melanoma and cancer‐associated fibroblasts promotes invasion and proliferation

  2016cites this paper
• Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis.

  2016cites this paper
• First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma

  2016cites this paper
• Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2

  2016cites this paper
• Identification des régulateurs de l’expression transcriptionnelle de TSPAN8 impliqués dans l’invasion précoce du mélanome cutané

  2016influential citation
• A novel apoptosis-inducing mechanism of 5-aza-2'-deoxycitidine in melanoma cells: Demethylation of TNF-α and activation of FOXO1.

  2015cites this paper
• Reduced Expression of RECK Protein May Help Differentiate Cutaneous Malignant Melanoma from Melanocytic Nevus.

  2015cites this paper
• Epigenetics of Melanoma

  2015cites this paper
• Effects of suppressor of cytokine signaling 1 silencing on human melanoma cell proliferation and interferon-γ sensitivity.

  2015cites this paper
• (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.

  2015cites this paper
• Update on melanoma epigenetics

  2015cites this paper
• Epigenetic regulation in human melanoma: past and future

  2015cites this paper
• MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor

  2015cites this paper
• Cellular Mechanisms of Oxidative Stress and Action in Melanoma

  2015cites this paper
• New Insights in Cutaneous Melanoma Immune-Therapy — Tackling Immune-Suppression and Specific Anti-Tumoral Response

  2015cites this paper
• [SOCSJ gene mutations in patients with diffuse large B-cell lymphoma].

  2015cites this paper
• MiR-21: an environmental driver of malignant melanoma?

  2015cites this paper
• Angiogenic and Metastatic Determinants of Malignant Melanoma

  2015cites this paper
• Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance.

  2015cites this paper
• Association of TNFRSF10D DNA-Methylation with the Survival of Melanoma Patients

  2014cites this paper
• The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.

  2014cites this paper
• World Health Organization SSM : superficial spreading melanoma LMM : lentigo maligna melanoma NM : nodular melanoma ALM : acral lentiginous melanoma CLASSIFICATION OF MELANOCYTIC NEOPLASMS

  2014cites this paper
• Gene Expression Profiling in Melanoma

  2014cites this paper
• DNA Methylation Characteristics of Primary Melanomas with Distinct Biological Behaviour

  2014cites this paper
• Single-cell gene expression signatures reveal melanoma cell heterogeneity

  2014cites this paper
• Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer

  2014influential citation
• Constitutional promoter methylation and risk of familial melanoma

  2014cites this paper
• FOR THE DEGREE OF DOCTOR OF PHILOSOPHY ( PHD )

  2014cites this paper
• Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.

  2013cites this paper
• Genome‐wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma

  2013cites this paper
• Up-Regulation of miR-182 Expression after Epigenetic Modulation of Human Melanoma Cells

  2013cites this paper
• Genes and signaling pathways affecting the pathogenesis of melanoma

  2013cites this paper
• Diagnostic implications of loss of 5-hydroxymethylcytosine for melanoma

  2013cites this paper
• Characterization of distinct molecular genetic alterations in BRAF and NRAS mutated human primary melanoma

  2013cites this paper
• Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma.

  2013cites this paper
• C URRENT OPINION New developments in biomarkers for melanoma

  2013cites this paper
• SOCS, inflammation, and cancer

  2013cites this paper
• Epigenetic dysregulation of novel candidate genes in melanoma

  2013cites this paper
• ESTUDIO DE LAS ALTERACIONES EN LA METILACIÓN DEL ADN EN PROGRESIÓN TUMORAL

  2013cites this paper
• Epigenetics of melanoma: implications for immune-based therapies.

  2013cites this paper
• New developments in biomarkers for melanoma

  2013cites this paper
• Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration

  2013cites this paper
• Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune.

  2012cites this paper
• ESTUDO DE VIA DE PI3K EM MELANOMAS DE CORÓIDE

  2012cites this paper
• Melanoma and epigenetic treatment: past and future.

  2012cites this paper
• Epigenetic Biomarkers in Melanoma

  2012cites this paper
• Role of SOCS1 in tumor progression and therapeutic application

  2012cites this paper
• Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.

  2012cites this paper
• Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance.

  2012cites this paper
• Melanoma and epigenetic treatment: past and future.

  2012cites this paper
• Aquaporins mediate the chemoresistance of human melanoma cells to arsenite

  2012cites this paper
• Tissue Microarray-Based Evaluation of Chromatin Assembly Factor-1 (CAF-1)/p60 as Tumour Prognostic Marker

  2012cites this paper
• Genetic, Epigenetic and Molecular Changes in Melanoma: A New Paradigm for Biological Classification

  2011cites this paper